Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy. [electronic resource]
Producer: 20090616Description: 2147-54 p. digitalISSN:- 0008-543X
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 19
- Cyclophosphamide -- therapeutic use
- Cytarabine -- administration & dosage
- Dexamethasone -- therapeutic use
- Doxorubicin -- therapeutic use
- Humans
- Methotrexate -- administration & dosage
- Middle Aged
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Translocation, Genetic
- Treatment Outcome
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.